New deodorant promises to slow down the growth of underarm hair
For years, research has hinted that the time of day that cancer patients receive chemotherapy can impact their chances of survival. But the lack of a clear scientific explanation for this finding has kept clinicians from considering timing as a factor in treatment. Now, a new study from the University of North Carolina at Chapel
Full Post: Time of day influences response to chemotherapy
The global giant Unilever which specialises in home, personal care and foods products has promised women a new deodorant which will apparently slow down the growth of underarm hair.
Unilever plans to launch the products in the UK next month which will be presented as both sprays and ‘roll-on’ deodorants under the names Sure and Dove Hair Minimising deodorants.
The company says the innovative new products are the result of three years research and they will not only slow down the growth of underarm hair and make it finer but will also reduce irritation caused by regrowth.
The new deodorant is not intended to replace other hair removal methods but instead discourage hair growth.
Unilever says a change is apparent after just four weeks of use but normal growth will quickly return if the product is not used.
The hair-minimising products are expected to create £10 million in sales in their first year.
Unilever says the product must not be used anywhere other than the armpits, which might worry for some who might wonder why a product is safe under the arms but not on other body areas.
Every day we all lose thousands and thousands of scalp hairs – men and women. New follicles grow in their place all the time so we don’t notice this hair loss, unless you are going bald. If this is the case, you are probably a man in the 25-40 year age group. Baldness affects men more
Full Post: Propecia is one such drug that has proved to be very successful in treating male baldness
Scientists in Beijing say they have discovered a genetic cause for a certain type of premature baldness and they suggest their discovery offers hope in future that those who inherit this rare type of baldness will eventually be able to keep their hair. A team from Peking Union Medical College led by Xue Zhang
Full Post: Culprit found in rare type of baldness
The Therapeutic Goods Administration (TGA) have recalled two types of cold and flu tablets following reports of a number of allergic and anaphylactic reactions. The national recall applies to all packets of Nyal Cold and Flu Fighter, and Nyal Cold and Flu Fighter Day and Night and the TGA has advised people who have these
Full Post: Warning about severe allergic reactions to recalled cold and flu tablets
The U.S. Food and Drug Administration recently approved the injectable drug degarelix, the first new drug in several years for prostate cancer. Degarelix is intended to treat patients with advanced prostate cancer. It belongs to a class of agents called gonadotropin releasing hormone (GnRH) receptor inhibitors. These agents slow the growth and progression of
Full Post: FDA approves injectable drug degarelix for advanced prostate cancer
Agricultural crop production relies on composted waste materials and byproducts, such as animal manure, municipal solid waste composts, and sewage sludge, as a necessary nutrient source. Studies have shown that human hair, a readily available waste generated from barbershops and hair salons, combined with additional compost, is an additional nutrient source for crops. Although human
Full Post: Human hair waste may be a viable option as fertilizer for edible crops